MarketPulse — Real-Time Financial News & Market Analysis

Nvidia reports Q4 earnings Feb 25 with focus on Blackwell GPU demand, competition threats to margins, and potential China market reopening worth $50B annually.

Enbridge authorizes CA$14B in 2025 capital projects with CA$39B backlog through 2033, supporting 5% annual earnings growth and consistent dividend increases.

Dyne Therapeutics will present five neuromuscular disease presentations at MDA 2026, showcasing cardiopulmonary data from DMD trial and Phase 3 design for myotonic dystrophy treatment.

Alphabet and Meta offer attractive valuations below 30 P/E ratios while investing heavily in AI, supported by strong revenue growth and massive user bases.

Rocket Lab's 900% revenue growth is impressive, but its $40B valuation may already price in future gains amid thin margins and shareholder dilution concerns.

Analyst recommends ExxonMobil, Visa, and ASML over Walmart, citing the retailer's elevated valuation and modest growth prospects compared to these alternatives' stronger fundamentals.

Ethereum meme coin Pepeto raises $7.3M in presale, with Binance listing planned. Bitcoin rally fuels investor interest in altcoins.

CrowdStrike reports strong 22% revenue growth but remains unprofitable. Stock down 17% YTD with elevated 21x price-to-sales valuation, raising execution concerns.

Investors are turning to inverse financial ETFs like SKF for short-term downside protection amid market volatility, though these leveraged instruments carry substantial risks and require active management.

IonQ and Rigetti offer different quantum computing investment approaches: IonQ is lower-risk with cloud partnerships; Rigetti is higher-risk but potentially differentiated. Both suit only patient investors.

Perceptive Advisors doubles investment in Praxis Precision Medicines to $588M, now largest holding. Stock surges 320% amid FDA submissions and strong cash position.

Perceptive Advisors doubled its Celcuity stake to 5.62% of AUM, making it the fund's second-largest holding. Stock surged 700% YoY ahead of expected FDA approval for lead drug Gedatolisib.

Visa and Moody's stocks declined despite strong operations, facing regulatory pressure and sector headwinds. Both retain solid earnings and analyst support, offering potential recovery as conditions stabilize.

Arohi Asset Management exits DoubleVerify stake entirely, selling 1.7 million shares for $20.6 million as the ad verification firm's stock tumbles 58.5% amid profitability concerns.

Redmile Group adds $63M to Nurix stake despite stock decline, betting on promising BTK degrader clinical data and upcoming registrational trials.

Johnson & Johnson maintains Dividend King status with 63 consecutive years of dividend increases, offering stable income through its diversified healthcare business and AAA credit rating.

Intuitive Surgical faces near-term headwinds but maintains strong long-term growth potential through its dominant robotic surgery platform, structural competitive advantages, and expanding market opportunities.

Dean Capital Management invests $3.5M in Chesapeake Utilities, acquiring 1.48% stake in the diversified utility operator serving eastern U.S. markets.

Druckenmiller tripled his Alphabet stake for AI exposure while avoiding Nvidia, preferring cloud infrastructure over chip plays due to valuation concerns.

Alphabet accelerates AI integration across products as search revenue grows 17%. Gemini reaches 750M users, strengthening the company's competitive position in AI development.